BioSpace News Archive

Abveris, Inc., a global leader in contract research antibody discovery, and Harbour Antibodies H2L2 BV, a wholly-owned subsidiary of Harbour BioMed, today announced a partnership to offer fully-human antibody discovery service that combines Abveris’ antibody discovery services with the Harbour H2L2 human transgenic mouse platform.

Medscape, the leading news and information platform for physicians worldwide, announced an updated editorial policy that highlights its longstanding commitment to transparency and objectivity.

Participation in the round table session named “Novel hearing therapeutics; what does it mean for the ENT surgeon?”

Agreement signed for South Africa, Namibia, Botswana, Zimbabwe, Swaziland, Lesotho, Malawi, Kenya, Uganda

TRINITY, a strategic partner to leading life sciences companies, officially opened its flagship European office in Munich, Germany.

First clinical study of a rationally-defined bacterial consortium (VE416) for treating food allergy, will initially be studied in patients with history of peanut allergy

Merck’s supply chain and eCommerce strength will allow broader availability and accessibility of the Fire Monkey / Fire Flower product to customers

Peroxfarma, a leading European health and wellness company, will invade America this year with its Epaplus nutritional supplements that were developed for joint care, sleep issues, digestion problems and bolstering the immune system

Company Recognized for Novel Solution to Combat Growing Threat of Antibiotic Resistance

Independent third party Phase 2 results show Teplizumab, a mouse derived humanized anti-CD3 monoclonal antibody (mAb) significantly slowed progression of Type 1 diabetes in high risk population